DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
D’Haens G, Reinisch W, Satsangi J. et al.
Long-term safety of adalimumab in patients with Crohn’s disease: final data from PYRAMID registry.
J Crohn Colitis 2017;
11 (Suppl. 01) P353
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.